APA (7th ed.) Citation

UM, L., A, A., S, P., GI, S., C, T., SA, P., . . . P, S. (2025). Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma. ESMO open, 10(5), 104499. https://doi.org/10.1016/j.esmoop.2025.104499

Chicago Style (17th ed.) Citation

UM, Lauer, et al. "Final Results from the Phase Ia/Ib Study of the Novel Bromodomain and Extra-terminal Domain Inhibitor, BI 894999, in Patients with Advanced Solid Tumors or Diffuse Large B-cell Lymphoma." ESMO Open 10, no. 5 (2025): 104499. https://doi.org/10.1016/j.esmoop.2025.104499.

MLA (9th ed.) Citation

UM, Lauer, et al. "Final Results from the Phase Ia/Ib Study of the Novel Bromodomain and Extra-terminal Domain Inhibitor, BI 894999, in Patients with Advanced Solid Tumors or Diffuse Large B-cell Lymphoma." ESMO Open, vol. 10, no. 5, 2025, p. 104499, https://doi.org/10.1016/j.esmoop.2025.104499.